Significance of early measurement of serum hepatitis C virus RNA in predicting response to interferon therapy in patients with chronic hepatitis C

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 3, 1997, Pages 245-249

  Toyoda, Hidenori ^a   Kumada, Takashi ^a   Nakano, Satoshi ^a   Takeda, Isao ^a   Sugiyama, Keiichi ^a   Kiriyama, Seiki ^a   Sone, Yasuhiro ^a   Miyata, Akihiro ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Chronic hepatitis C; Early measurement; HCV RNA; Interferon therapy; Response

Indexed keywords

ALPHA INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030904040     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199703000-00005     Document Type: Article

References (20)

1. Hoofnagle JH, Mullen KD, Jones DB, et al.: Treatment of chronic non-A, non-B, hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986, 315:1575-1578.
2. Thomson BJ, Doran M, Lever AML, et al.: Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy. Lancet 1987, i:539-541.
3. Davis GL, Balart LA, Schiff ER, et al.: Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized controlled trial. N Engl J Med 1989, 321:1501-1506.
4. Di Bisceglie AM, Martin P, Kassiandies C, et al.: Recombinant interferon alpha therapy for chronic hepatitis C. N Engl J Med 1989, 321:1506-1510.
5. Jacyna MR, Brooks MG, Loke RHT, et al.: Randomized controlled trial of interferon alpha (lymphoblastoid interferon) in chronic non-A, non-B hepatitis. BMJ 1989, 298:80-82.
6. Shindo M, Di Bisceglie A, Cheung L, et al.: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991, 115:700-704.
7. Hagiwara H, Hayashi N, Mita E, et al.: Quantitative analysis of hepatitis C virus in serum during interferon alpha therapy. Gastroenterology 1993, 104:877-883.
8. Lau JYN, Davis GL, Kniffen J, et al.: Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993, 341:1501-1504.
9. Kanai K, Kato M, Okamoto H: HCV genotype in chronic hepatitis C and response to interferon. Lancet 1992, 339:1543.
10. Yoshioka K, Kakumu S, Wakita T, et al.: Detection of hepatitis C virus by polymerase chain reaction and response to interferon alfa therapy: relation to genotypes of hepatitis C virus. Hepatology 1992, 16:293-299.
11. Matsumoto A, Tanaka E, Suzuki T, et al.: Viral and host factors that contribute to efficacy of interferon-α 2a therapy in patients with chronic hepatitis C. Dig Dis Sci 1994, 39:1273-1280.
12. Toyoda H, Nakano S, Kumada T, et al.: Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-α therapy in chronic hepatitis C patients. J Med Virol 1996, 48:354-359.
13. Shibata M, Morishima T, Kudo T, et al.: Serum hepatitis C virus sequences in post-transfusion non-A, non-B hepatitis. Blood 1991, 77:1157-1160.
14. Desmet VJ, Gerber M, Hoofnagle JH, et al.: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994, 19:1513-1520.
15. Okamoto H, Sugiyama Y, Okada S, et al.: Typing hepatitis C virus by polymerase chain reaction with type-specific primers. An application to clinical surveys and tracing infection scores. J Gen Virol 1992, 73:673-679.
16. Simmonds P, Alberti A, Alter HJ, et al.: A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994, 19:1321-1324.
17. Urdea MS, Kolberg J, Warner BD: A novel method for the detection of hepatitis B virus in human serum samples without blotting or radioactivity. In Luminescence Immunoassay and Molecular Applications. Edited by van Dyke K, Dyke R, Boca Raton: CRC Press; 275-291.
18. Enomoto N, Sakuma I, Asahina Y, et al.: Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J Clin Invest 1995, 96:224-230.
19. Chayama K, Tsubota A, Arase Y, et al: Genotype, slow decrease in virus titer during interferon treatment and high degree of sequence variability of hypervariable region are indicative of poor response to interferon treatment in patients with chronic hepatitis type C. J Hepatol 1995, 23:648-653.
20. Hino K, Okuda M, Konishi T, et al.: Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy. Dig Dis Sci 1995, 40:14-20.